Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Fred Saad
Based on 180 articles published since 2007
||||
Expertise Level
The expertise of Fred Saad ranks in the
  • Top 0.006%
  • ... of 132,893 published authors worldwide on Prostatic Neoplasms
  • ... from 2007 through 2018
  • ... based on contributions to 180 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Miscellaneous institutions in Montreal      
2018
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg- Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada; Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy, Vita-Salute San Raffaele University, Milan, Italy. · Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada. · Department of Urology, Istituto Europeo di Oncologia, Milan, Italy. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg- Eppendorf, Hamburg, Germany. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg- Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg- Eppendorf, Hamburg, Germany. · Department of Urology, IRCCS Fondazione Ca' Granda-Ospedale Maggiore Policlinico University of Milan, Milan, Italy. · Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy, Vita-Salute San Raffaele University, Milan, Italy. · Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada. · Pubmed 29784507
2017
  • University of Colorado, Denver, CO. Electronic address: · Yale University, New Haven, CT. · Carolina Urologic Research Center, Myrtle Beach, SC. · Centre Hospitalier de L'Universite de Montreal, Montreal, QC, Canada. · Memorial Sloan Kettering Cancer Center, New York, NY. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV. · Medical University of South Carolina, Charleston, SC. · Banner MD Anderson Cancer Center, Gilbert, AZ. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA. · Queen's University Belfast, Belfast, Northern Ireland, UK. · Université Catholique de Louvain, Brussels, Belgium. · Comprehensive Prostate Center, Nashville, TN. · Lancaster Urology, Lancaster, PA. · Icahn School of Medicine at Mount Sinai, New York, NY. · NRG Immunotherapy and Immunomodulation Committee, Scottsdale, AZ. · University of Washington, Seattle, WA. · Pubmed 28302580
  • OHSU Knight Cancer Institute, Portland, OR, USA. Electronic address: · Juravinski Cancer Centre, Hamilton, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Institut du Cancer de Montréal, Montréal, QC, Canada. · P A Herzen Moscow Cancer Research Institute, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · N N Blokhin Cancer Research Center, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · Centre Leon Berard, Lyon, France. · Institute Paoli-Calmettes, Marseille, France. · Centre François Baclesse, Caen, France. · University of British Columbia, BC Cancer Agency-Vancouver Centre, Vancouver, BC, Canada. · The Clatterbridge Cancer Centre, Bebington, UK. · Trial Architecture Consulting, Washington, DC, USA. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Gustave Roussy, University of Paris Saclay, Villejuif, France. · Pubmed 29033099
  • Department of Medicine, Division of Medical Oncology, University of British Columbia, BC Cancer Agency, Vancouver Prostate Centre, Vancouver, BC, Canada. Electronic address: · Department of Medicine, Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Trial Architecture Consulting, Washington, DC, USA. · Centre Antoine Lacassagne, Nice, France. · Florida Cancer Specialists, Fort Myers, FL, USA. · Department of Urology, Tübingen, Germany. · Institut Paoli Calmette, Department of Cancer Medicine, Marseille, France. · Department of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany. · University of Tübingen, Tübingen, Germany. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON, Canada. · Durham Regional Cancer Centre, Oshawa, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Department of Medicine, Division of Medical Oncology, University of British Columbia, BC Cancer Agency, Vancouver Prostate Centre, Vancouver, BC, Canada. · Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Pubmed 28283282
  • Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Toronto, ON, Canada. · Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900 St Denis St, Montreal, QC, Canada. · McGill University and McGill University Health Centre, 1001 Decarie Blvd, Montreal, QC, Canada. · University Health Network, 610 University Ave, Toronto, ON, Canada. · Manitoba Prostate Centre, 675 McDermot Ave, Winnipeg, MB, Canada. · Department of Surgery Université de Montréal, 2900 Edouard Montpetit Blvd, Montreal, QC, Canada. · Terrry Fox Research Institute, 675 West 10th Avenue, Vancouver, BC, Canada. · Vancouver Prostate Centre, 2660 Oak St, Vancouver, BC, Canada. · Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900 St Denis St, Montreal, QC, Canada. · Department of Surgery Université de Montréal, 2900 Edouard Montpetit Blvd, Montreal, QC, Canada. · Department of Medicine, Université de Montréal, 2900 Edouard Montpetit Blvd, Montreal, QC, Canada. · Pubmed 29078772
  • Duke Cancer Institute, Durham, North Carolina. · Centre Hospitalier de l'Université de Montréal and CRCHUM, Montreal, Quebec, Canada. · Astellas Pharma, Inc., Leiden, Netherlands. · Astellas Pharma, Inc., Northbrook, Illinois. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · Institut Gustave Roussy, University of Paris Sud, Paris, France. · Medivation, Inc., San Francisco, California. · Sidney Kimmel Center for Prostate and Urologic Cancers and Memorial Sloan-Kettering Cancer Center, New York, New York. · Institute of Cancer Research, London, UK. · Pubmed 28171710
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)/Institut du Cancer de Montréal, Montreal, Canada. · Department of Surgery, Hôpital Saint Luc (CHUM), Montreal, Canada. · Department of Surgery, Université de Montréal, Montreal, Canada. · Department of Medicine, Université de Montréal, Montreal, Canada. · Pubmed 27577074
  • University Health Network, Toronto, ON, Canada. · Institut du Cancer de Montréal/Centre de recherche du CHUM, Montreal, QC, Canada. · Manitoba Prostate Center, Winnipeg, MB, Canada. · Centre de Santé et des Services Sociaux de Laval, Laval, QC, Canada. · Centre hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada. · Vancouver Prostate Center, Vancouver, BC, Canada. · Centre de Santé et des Services Sociaux de Chicoutimi, Chicoutimi, QC, Canada. · Centre hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada. · Institut du Cancer de Montréal/Centre de recherche du CHUM, Montreal, QC, Canada. · Pubmed 27447989
2016
  • University of Warwick, Cancer Research Unit, Coventry, UK; Queen Elizabeth Hospital, Birmingham, UK. · Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada. Electronic address: · Pubmed 26905032
  • Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. Electronic address: · Vall d' Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Kantonsspital St Gallen, St Gallen, Switzerland. · University Hospital, University Hospital Cologne, Germany. · Department of Oncology, Akershus University Hospital, Lørenskog, Norway. · Modular Informatics LLC, Thornwood NY, USA. · Biometrical Practice, BIOP, Basel, Switzerland. · Charité University Medicine Berlin, Berlin, Germany. · Karolinska University Hospital, Stockholm, Sweden. · Pharmaceuticals Division of Bayer, Whippany, NJ, USA. · Department of Oncology, San Luigi Hospital, Orbassano Turin, Italy. · University Hospital Carl-Gustav Carus, Dresden, Germany. · Bayer Pharma AG, Basel, Switzerland. · The Centre for Cancer Research and Cell Biology, Queen's University Belfast, Northern Ireland; Northern Ireland Cancer Centre, Belfast, Northern Ireland. · Pubmed 27473888
  • 1 McGill University Health Centre and Research Institute , Montréal, Canada . · 2 PROCURE Alliance , Montréal, Canada . · 3 Montréal University Health Centre , Montréal, Canada . · 4 Québec University Health Centre , Québec, Canada . · 5 Sherbrooke University Health Centre , Sherbrooke, Canada . · Pubmed 27327090
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montréal, Quebec, Canada. Faculté de Pharmacie, Université de Montréal, Pavillon Jean-Coutu, Montréal, Quebec, Canada. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montréal, Quebec, Canada. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montréal, Quebec, Canada. Faculté de Pharmacie, Université de Montréal, Pavillon Jean-Coutu, Montréal, Quebec, Canada. · Pubmed 26253870
2015
  • Montréal University Health Centre, Montréal, Canada. Electronic address: · Department of Cancer Medicine, Gustave Roussy Institute, University of Paris Sud, Villejuif, France. · Pubmed 26282624
  • Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: · Academic Unit of Clinical Oncology, Weston Park Hospital, CR-UK/YCR Sheffield Cancer Research Centre, Sheffield, UK. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA; Department of Clinical Therapeutics, University of Athens, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Department of Internal Medicine, Section of Medical Oncology, UAB Medical Center, Birmingham, AL, USA. · Department of Medicine and Urology, Tulane University, New Orleans, LA, USA. · Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 26153564
  • Division of Urology, Department of Surgery, Centre Hospitalier de I'Université de Montréal, Montréal, Quebec, Canada. Electronic address: · Department of Urology, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany. · Pubmed 25709051
  • Centre Hospitalier de l'Université de Montréal/CRCHUM, Montréal, QC, Canada. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Universitatea de Medicina si Farmacie, Bucharest, Romania. · University of Athens Medical School, Athens, Greece. · Auckland City Hospital, Auckland, New Zealand. · Florida Cancer Specialists, Fort Myers, FL, USA. · Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. · The Adelaide and Meath Hospital, Incorporating the National Children's Hospital, Dublin, Ireland. · University Hospital Carl Gustav Carus Dresden, Dresden, Germany. · Gunma University Graduate School of Medicine, Gunma, Japan. · Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA. · The University of Tokyo Research Center for Advanced Science and Technology, Tokyo, Japan. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Cleveland Clinic, Cleveland, OH, USA. · Millennium Pharmaceuticals, Inc, Cambridge, MA, USA. · Erasmus University Medical Center, Rotterdam, Netherlands. · Pubmed 25701170
  • Epidemiology and Biostatistics Unit, Institut national de la recherche scientifique-Institut Armand-Frappier, University of Quebec, 531 Boul. des Prairies, Laval, QC, H7V 1B7, Canada. · Epidemiology and Biostatistics Unit, Institut national de la recherche scientifique-Institut Armand-Frappier, University of Quebec, 531 Boul. des Prairies, Laval, QC, H7V 1B7, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 1058, rue St-Denis, Montreal, QC, H2X 3 J4, Canada. · Department of Surgery, Division of Urology, Centre Hospitalier de l'Université de Montréal, 1058, rue St-Denis, Montreal, QC, H2X 3 J4, Canada. · Department of Surgery (Urology), McGill University Health Centre, 1650 Cedar Avenue, Montreal, QC, H3G 1A4, Canada. · Department of Surgery, Division of Urology, Centre Hospitalier de l'Université de Montréal, 1058, rue St-Denis, Montreal, QC, H2X 3 J4, Canada. · Epidemiology and Biostatistics Unit, Institut national de la recherche scientifique-Institut Armand-Frappier, University of Quebec, 531 Boul. des Prairies, Laval, QC, H7V 1B7, Canada. · Department of Social and Preventive Medicine, University of Montreal, 7101 Avenue du Parc, Montreal, QC, Canada. · Pubmed 26385727
  • Metamark Genetics Inc., Cambridge, Massachusetts. · Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. · Department of Pathology, Yale University Medical School, New Haven, Connecticut. · Urology Austin, Austin, Texas. · Impacts Inc., Montreal, Quebec, Canada. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio. · Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio. · Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Department of Pathology, Urology and Oncology, Johns Hopkins Hospital, Baltimore, Maryland. · Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 25733599
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Canada; Department of Urology, Vita Salute San Raffaele University, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Canada. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Department of Surgery, Division of Urology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Martini-Klinik, Prostate Cancer Center, University-Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Surgery, Division of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, Canada. · Department of Urology, Vita Salute San Raffaele University, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Canada; Department of Surgery, Division of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, Canada. · Pubmed 25547676
  • Department of Urology, Ruhr University Bochum, Marien Hospital, Herne, Germany. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Québec, Canada. · Department of Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Urology, University of California (UCLA), Los Angeles, CA. · Division of Urologic Surgery and Center for Surgery and Public Health, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Urology, Yale School of Medicine, New Haven, CT. · Department of Urology, Georgetown University Hospital, Washington, DC. · Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · CRCHUM, Centre Hospitalier de l׳Université de Montréal, Montreal, Québec, Canada. · Department of Urology, University of Minnesota, Minneapolis, MN. · Department of Urology, Ruhr University Bochum, Marien Hospital, Herne, Germany. · Division of Urologic Surgery and Center for Surgery and Public Health, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI. · Pubmed 25443265
2014
  • Claude-Bernard-Lyon-1 University and Department of Medical Oncology, Centre Léon-Bérard, Lyon, France. Electronic address: · Multidisciplinary Oncology Institute, Clinique de Genolier, Genolier, Switzerland. · H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. · Claude-Bernard-Lyon-1 University and Department of Medical Oncology, Centre Léon-Bérard, Lyon, France. · Department of Urology, University Hospitals, Leuven, Belgium. · Department of Urology, Queen Mary University of London, London, UK. · Division of Surgery and Interventional Science, University College London, London, UK. · Department of Clinical Therapeutics, University of Athens Medical School, Athens, Greece. · Irish Cancer Society and University College Dublin, Dublin, Ireland. · Department of Urology, RWTH University Aachen, Aachen, Germany. · Guy's and St Thomas' NHS Trust, London, UK. · Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA. · University Hospital, Saint-Etienne, France. · Georges Pompidou Hospital, Department of Oncology, Paris, France. · University College London Hospitals, London, UK. · Uro‑Oncology Clinic, Centre Hospitalier de l'Université de Montreal, Montreal, QC, Canada. · Pubmed 25079103
  • Department of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: · Academic Unit of Clinical Oncology, Weston Park Hospital, CR-UK/YCR Sheffield Cancer Research Centre, Sheffield, UK. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Urology, University Hospital Charité, Berlin, Germany. · Division of Urology, Centre Hospitalier de l'Université de Montréal, CRCHUM, Montréal, QC, Canada. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Tisch Cancer Center Institute, Mount Sinai School of Medicine, New York, NY, USA. · Pubmed 23706567
  • Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. Electronic address: · Pubmed 22633317
2017
  • Division of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 28644302
2015
  • a 1 Institut du cancer de Montréal, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Quebec, Canada. · Pubmed 26313417
  • Department of Radiation Oncology, Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada. · Pubmed 26271398
2013
  • Centre de Recherche, Centre Hospitalier de l'Université de Montréal, 1560 Sherbrooke East, Montréal, QC H2L 4M1, Canada. · Pubmed 23797341
2012
  • Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada. · Pubmed 22871982
  • Goodman Cancer Research Centre, Montréal, Québec, Canada. · Pubmed 22282656
  • Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada. · Pubmed 21932427
2011
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du Cancer de Montréal, Montreal, Quebec, Canada. · Pubmed 21438025
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM)/Institut du Cancer de Montréal, Québec, Canada. · Pubmed 21271611
2010
  • Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM) and Institut du cancer de Montréal, Montreal, Quebec, Canada. · Pubmed 20711410
2009
  • Centre de recherche du Centre hospitalier de l'Université de Montréal/Institut du cancer de Montréal, Québec, Canada. · Pubmed 19170126
2008
  • Centre de recherche du centre hospitalier de l'Université de Montréal (CR-CHUM), Institut du cancer de Montréal, Quebec, Canada. · Pubmed 18294307
2007
  • Urologic-Oncology Division, Centre Hospitalier de l'Université de Montréal, Canada. · Pubmed 18685362
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal and Institut du Cancer de Montréal, Québec, Canada. · Pubmed 18056181
  • Centre de recherche du Centre Hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada. · Pubmed 17532856
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal/Institut du cancer de Montréal, Montréal, Québec, Canada H2L 4M1. · Pubmed 17259348
Probable:    Universite de Montreal      
2017
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Martini Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology, SS Annunziata Hospital, G.D. Annunzio University of Chieti, Chieti, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Martini Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Academic Hospital Braunschweig, Braunschweig, Germany. · Department of Radiation Oncology, University of Montreal Health Center, Montreal, Canada. · Martini Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Martini Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 28546065
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Cancer Medicine, Institute Gustave Roussy, Villejuif, France. · Department of Oncology, University of Paris, Paris, France. · Janssen Oncology Research & Development, Raritan, New Jersey. · Janssen Research & Development, Menlo Park, California. · Millennium Pharmaceuticals Inc., Cambridge, Massachusetts. · Department of Surgery, University of Montréal, Montréal, Québec, Canada. · Prostate Cancer Targeted Therapy Group, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Pubmed 27678453
  • Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. Electronic address: · Duke Cancer Institute, Durham, NC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave-Roussy, Villejuif, France. · San Camillo and Forlanini Hospitals, Rome, Italy. · University of Washington, Seattle Cancer Care Alliance, Seattle, WA, USA. · Rigshospitalet, Copenhagen, Denmark. · UC Davis Cancer Center, Sacramento, CA, USA. · Asan Medical Center, Seoul, Korea. · Nippon Medical School, Tokyo, Japan. · Charité Universitätsmedizin, Berlin, Germany. · University of Montreal Hospital Center, Montreal, QC, Canada. · Skåne University Hospital, Malmö, Sweden. · Aarhus University Hospital, Aarhus, Denmark. · Radboud University Medical Center, Nijmegen, Netherlands. · Tampere University Hospital and University of Tampere, Tampere, Finland. · Medivation, San Francisco, CA, USA. · Astellas Pharma Europe, Leiden, The Netherlands. · Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27477525
  • Janssen Research & Development, 920 Route 202, Raritan, NJ, 08869, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, a Division of Janssen Pharmaceutica NV, Beerse, Belgium. · Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA. · University of Montréal, Montréal, QC, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, 920 Route 202, Raritan, NJ, 08869, USA. · Pubmed 27324190
  • Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Toronto, ON, Canada. · Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900 St Denis St, Montreal, QC, Canada. · McGill University and McGill University Health Centre, 1001 Decarie Blvd, Montreal, QC, Canada. · University Health Network, 610 University Ave, Toronto, ON, Canada. · Manitoba Prostate Centre, 675 McDermot Ave, Winnipeg, MB, Canada. · Department of Surgery Université de Montréal, 2900 Edouard Montpetit Blvd, Montreal, QC, Canada. · Terrry Fox Research Institute, 675 West 10th Avenue, Vancouver, BC, Canada. · Vancouver Prostate Centre, 2660 Oak St, Vancouver, BC, Canada. · Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900 St Denis St, Montreal, QC, Canada. · Department of Surgery Université de Montréal, 2900 Edouard Montpetit Blvd, Montreal, QC, Canada. · Department of Medicine, Université de Montréal, 2900 Edouard Montpetit Blvd, Montreal, QC, Canada. · Pubmed 29078772
  • Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. Electronic address: · University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Research & Development, Beerse, Belgium. · Janssen Global Services, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Pubmed 28314611
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Martini-Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Department of Urology, University Hcoospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Academic Hospital Braunschweig, Braunschweig, Germany. · Pubmed 28156003
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)/Institut du Cancer de Montréal, Montreal, Canada. · Department of Surgery, Hôpital Saint Luc (CHUM), Montreal, Canada. · Department of Surgery, Université de Montréal, Montreal, Canada. · Department of Medicine, Université de Montréal, Montreal, Canada. · Pubmed 27577074
  • The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Centre Hospitalier University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Global Services, Raritan, NJ, USA. · University of Colorado Cancer Center, Aurora, CO, USA. · Pubmed 27402060
2016
  • Department of Urology, UC Davis Comprehensive Cancer Center, Sacramento, CA, USA. Electronic address: · Medical Oncology Division, University of Washington/Seattle Cancer Care Alliance, Seattle, WA, USA. · Department of Urology, Medical University of South Carolina, Charleston, SC, USA. · Division of Urologic Surgery, Washington University School of Medicine, St. Louis, MO, USA. · Department of Surgery, University of Montreal Health Center, Montreal, Canada. · Copenhagen Prostate Cancer Center, Rigshospitalet, University of Copenhagen, Denmark. · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Urology, Asan Medical Center, Seoul, South Korea. · Department of Urology, Nippon Medical School Hospital, Tokyo, Japan. · Division of Medical Oncology and Urology, Duke Cancer Institute, Durham, NC, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave-Roussy, Villejuif, France. · Drug Development Unit, Institute of Cancer Research, Royal Marsden Hospital, London, UK. · Department of Early Clinical Development, Medivation, Inc., San Francisco, CA, USA. · Department of Medical Affairs, Medivation, Inc., San Francisco, CA, USA. · Department of Biostatistics, Medivation, Inc., San Francisco, CA, USA. · Astellas Pharma, Inc., Northbrook, IL, USA. · Department of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27006332
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Janssen Research & Development, San Diego, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · University of Montréal, Montréal, Québec, Canada. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Monash University and Eastern Health, Victoria, Australia. · ZNA Middelheim Oncology Clinic, Medical Oncology, Antwerp, Belgium. · Churchill Hospital, Oxford, UK. · Janssen Research & Development, Menlo Park, CA, USA. · Janssen Research & Development, Beerse, Belgium. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Georges Pompidou Hospital, University René Descartes, Paris, France. · Pubmed 26508309
  • University of Montreal Hospital Center (CHUM) and Montreal Cancer Institute/CRCHUM, CHUM - Pavillon R 900, rue St-Denis, porte R10-464, Montréal, Québec H2X 0A9, Canada. · Pubmed 27489183
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Québec, Canada; Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Québec, Canada; Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Québec, Canada; Department of Urology, University of Montreal Health Center, Montreal, Québec, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Québec, Canada. · Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, Medical University of Vienna and General Hospital, Vienna, Austria. · Department of Urology, University of Montreal Health Center, Montreal, Québec, Canada. · Pubmed 27478167
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, Medical University of Vienna and General Hospital, Vienna, Austria. · Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Pubmed 26951945
  • Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Unit of Urology, Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. · INRS-Institut Armand-Frappier, Institut national de la recherche scientifique, Université du Québec, Laval, Canada. · Department of Social and Preventive Medicine, University of Montreal, Montreal, Canada. · Pubmed 26108732
2015
  • University of Montreal Hospital Center, Montreal, Quebec, Canada. Electronic address: · Pubmed 25168615
  • Centre Hospitalier de l'Université de Montréal, University of Montreal, CHUM Pavillon R, 900 rue St Denis, Montreal, QC H2X 0A9, Canada. · Pubmed 25600097
  • Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (D.B.M., H.S., H.F.), Cambridge, Massachusetts 02139; and University of Montreal Hospital Center (F.S.), Montreal, Québec, Canada H2X 0A9. · Pubmed 26502357
  • Janssen Research & Development, Raritan, New Jersey. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Janssen Research & Development, Beerse, Belgium. · Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · University of Montreal, Montreal, Quebec, Canada. · Janssen Research & Development, Los Angeles, California. · Janssen Research & Development, Raritan, New Jersey. · Pubmed 25829400
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University of Montréal, Montréal, Québec, Canada. · Radboud University Medical Centre, Nijmegen, Netherlands. · San Camillo and Forlanini Hospitals, Rome, Italy. · Charité Berlin, Berlin, Germany. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · University of Western Sydney School of Medicine and Ingham Institute, Liverpool, Australia. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, United Kingdom. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 25601341
  • University of Montreal Hospital Centre, Montreal, QC, Canada. Electronic address: · Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Gustave Roussy, Cancer Campus Grand Paris, University of Paris Sud, Villejuif, France. · Medivation, Inc., San Francisco, CA, USA. · Astellas Global Medical Affairs, Inc., Northbrook, IL, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 25171902
  • Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · INRS-Institut Armand-Frappier, Institut national de la recherche scientifique, Université du Québec, Laval, Canada. · Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · INRS-Institut Armand-Frappier, Institut national de la recherche scientifique, Université du Québec, Laval, Canada; Department of Social and Preventive Medicine, University of Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology, University of Montreal Health Center, Montreal, Canada. · Pubmed 26278366
  • Institut du cancer de Montréal / Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), 900 rue St-Denis, Montreal, Canada. · Visiopharm, Argen Allé 3, Hoersholm, Denmark. · Institut du cancer de Montréal / Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), 900 rue St-Denis, Montreal, Canada; Department of Medicine, Université de Montréal, Montreal, Canada. · Institut du cancer de Montréal / Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), 900 rue St-Denis, Montreal, Canada; Division of Urology, CHUM and Department of Surgery, Université de Montréal, Montreal, Canada. · Pubmed 26186215
  • Department of Surgery, University of Montreal, Montreal, Quebec, Canada. · Pubmed 26181183
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, Montreal, QC, H2X 1P1, Canada. · Department of Urology, University of Montreal Health Center, Montreal, QC, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, Montreal, QC, H2X 1P1, Canada. · Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Division of Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, QC, Canada. · University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada. · Department of Radiation Oncology, University of Montreal Health Center, Montreal, QC, Canada. · Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 25854524
  • Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, Montreal, QC, H2X 1P1, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, Montreal, QC, H2X 1P1, Canada. · Department of Urology, University of Montreal Health Center, Montreal, QC, Canada. · Division of Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · INRS-Institut Armand-Frappier, Institut national de la recherche scientifique, Université du Québec, Laval, QC, Canada. · Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. · Department of Social and Preventive Medicine, University of Montreal, Montreal, QC, Canada. · Pubmed 25824539
  • VUI Center for Outcomes Research, Analytics and Evaluation, Henry Ford Health System, Detroit, MI. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Urology, Yale University, New Haven, CN. · VUI Center for Outcomes Research, Analytics and Evaluation, Henry Ford Health System, Detroit, MI; Division of Urologic Oncology and Center for Surgery and Public Health, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Urology, University of Minnesota, Minneapolis, MN. · Department of Urology, Maine Medical Center, Portland, ME. · Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA. · Division of Urologic Oncology and Center for Surgery and Public Health, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Division of Urology, University of Montreal Hospital Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Division of Urologic Oncology and Center for Surgery and Public Health, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 25623683
2014
  • University of Montreal, Montreal, Quebec, Canada. · Pubmed 25029395
  • Montefiore Medical Center, 111 East 210th Street, New York, NY 10467, USA. · Centre Hospitalier de I'Université de Montréal, Hôpital Notre-Dame, 1560 Sherbrooke East, Montreal, QC H2L 4M1, Canada. · Pubmed 24821212
  • Princess Margaret Hospital, Toronto, ON, Canada. Electronic address: · Durham VA Medical Center and Duke University Medical Center, Durham, NC, USA. · BC Cancer Agency, Vancouver, BC, Canada. · Seattle Cancer Centre Alliance, Seattle, WA, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. · Royal Marsden NHS Foundation Trust, Sutton, UK. · Tulane Cancer Center, New Orleans, LA, USA. · University of Montreal Hospital Center, Montreal, PQ, Canada. · Pubmed 23957948
  • Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. Electronic address: · Hospital Universitario 12 de Octubre, Madrid, Spain. · Rigshospitalet, Copenhagen, Denmark. · National Institute of Oncology, Budapest, Hungary. · McMaster University, Hamilton, ON, Canada. · ICON Cancer Care, Brisbane, QLD, Australia. · University of Montreal, Montreal, QC, Canada. · Center for Oncology, Hospital Sírio-Libanês, São Paulo, Brazil. · OncoCare Cancer Centre, Singapore. · Centro Oncologico Belenus, Cuernavaca, Mexico. · University of Pisa, Pisa, Italy. · Janssen Research & Development, Horsham, PA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Scientific Affairs, Horsham, PA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Global Services, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Duke Cancer Institute, Durham, NC, USA. · Pubmed 25242048
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • Departments of Surgery and Urology, University of Montreal Health Center, Montréal, Quebec, Canada H2X 0A9. · Pubmed 25130993
  • Associated Medical Professionals of New York, Syracuse, NY. · SUNY Upstate Medical University, Syracuse, NY. · Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada. · Associated Medical Professionals of New York, Syracuse, NY. Electronic address: · Division of Urology, University of Montreal Hospital Center, Montreal, Quebec, Canada. · Pubmed 24976229
  • Centre Hospitalier de I'Université de Montréal, Urology Division, Hôpital Notre-Dame, 1560 Sherbrooke Rast, Montreal, QC H2L 4M1, Canada. · Pubmed 24731994
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Urological Research Institute, Vita-Salute San Raffaele University, San Raffaele Hospital, San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Martini-clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Division of Urologic Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 24612110
  • Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: · Janssen Research & Development, Los Angeles, CA, USA. · Medical University of Vienna, Vienna, Austria. · University of Montreal, Montreal, QC, Canada. · University of Washington, Seattle, WA, USA. · British Columbia Cancer Agency, Vancouver, BC, Canada. · Janssen Research & Development, Raritan, NJ, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 24099659
  • University of Montreal Hospital Center, Montreal, Quebec, Canada. Electronic address: · Department of Urology, Charité Berlin, Berlin, Germany. · Pubmed 23506965
2012
  • Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany. · Pubmed 22409467
  • Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montréal, QC, Canada. · Pubmed 22307372
  • Centre Hospitalier de l'Université de Montréal and CRCHUM, 1560 Sherbrooke East, Montréal, Quebec H2L 4M1, Canada. · Pubmed 21864229
  • Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Pubmed 21163673
  • University of Montreal Health Center, Montreal, Quebec, Canada H2L 4M1. · Pubmed 22112794
2011
  • CRCUM-Université de Montréal, Hamilton, Ontario, Canada. · Pubmed 21788353
2010
  • Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Canada. · Pubmed 21110764
  • Centre Hospitalier de l'Université de Montréal, Quebec, Canada. · Pubmed 20682370
  • Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 20489645
  • University of Montreal, CHU Montreal, 1560 Sherbrooke East, Montreal, Quebec, Canada. · Pubmed 20015594
  • Centre Hospitalier de i'Université de Montréal, Hôpital Notre-Dame, Montréal, Quebec, Canada. · Pubmed 21056263
2009
2008
  • Department of Surgery/Urology, Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, Quebec, Canada. · Pubmed 18955443
  • University of Montreal, Montreal, Quebec, Canada. · Pubmed 18070191
  • Centre Hospitalier de I'Université de Montréal, Hôpital Notre-Dame, 1560 Rue Sherbrooke East, Montréal, Quebec, Canada PQ H2L 4M1. · Pubmed 18061356
  • University of Montreal Hospital Centre, Montreal, PQ, Canada. · Pubmed 18510661
2007
  • Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, 1560 Rue Sherbrooke East, Montréal, QC, Canada. · Pubmed 17264863
  • Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montréal, Quebec, Canada. · Pubmed 17956712
2018
  • From the Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago (M.H.), and Astellas Pharma, Northbrook (D.P., A.K.) - both in Illinois; Institut Gustave Roussy, University of Paris Sud, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.); Herlev Hospital, Herlev, Denmark (P.R.); Carolina Urologic Research Center, Myrtle Beach, SC (N.S.); State University of Campinas (Unicamp), Campinas, Brazil (U.F.); Kiev City Clinical Hospital 3, Kiev, Ukraine (P.I.); Pfizer, San Francisco (E.D., K.M.); and the Department of Medical Oncology, San Camillo Forlanini Hospital, Rome (C.N.S.). · Pubmed 29949494
  • From the Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston (M.R.S.); Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal (F.S.); Guy's, King's and St. Thomas' Hospitals, Great Maze Pond, London (S.C.); Georges Pompidou Hospital, Paris (S.O.); University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany (B.A.H.); Veterans Affairs Portland Health Care System, Portland, and Knight Cancer Institute, Oregon Health and Science University, Portland (J.N.G.); Spanish National Cancer Research Center, Madrid, and Hospitales Universitarios Virgen de la Victoria y Regional, Institute of Biomedical Research in Malaga, Malaga - both in Spain (D.O.); Centre for Personalised Nanomedicine, University of Queensland, Brisbane, Australia (P.N.M.); St. Mary's Hospital of Catholic University, Seoul, South Korea (J.Y.L.); Yokohama City University Medical Center, Yokohama, Japan (H.U.); Janssen Research and Development, Los Angeles (A.L.-G., G.C.T., B.M.E., Y.S., Y.C.P., W.R.R., M.K.Y.); and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco (E.J.S.). · Pubmed 29420164
2017
  • Emmanuel S. Antonarakis and Mario A. Eisenberger, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Scott T. Tagawa, Giuseppe Galletti, Daniel Worroll, Karla Ballman, Ada Gjyrezi, Shinsuke Tasaki, Luigi Portella, Yang Bai, Brian J. Kirby, David M. Nanus, and Paraskevi Giannakakou, Weill Cornell Medicine/Meyer Cancer Center; Che-Kai Tsao, Mount Sinai Medical Center, New York; Timothy B. Lannin, Shalu Suri, Conor N. Gruber, Erica D. Pratt, and Brian J. Kirby, Cornell University, Ithaca, NY; Marie Vanhuyse, Medical Oncology, Montréal General Hospital; Fred Saad, University of Montreal Hospital Center, Montreal; John Stewart, Atef Zaher, and Wei Zhou, Sanofi, Laval, Quebec, Canada; Guru Sonpavde, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; Scott North, University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada; Costantine Albany, Indiana University School of Medicine, Indianapolis, IN; and Ted Szatrowski, Sanofi, Bridgewater, NJ. · Pubmed 28632486
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Pubmed 27486887
2015
  • aFaculty of Medicine, University of Montreal bDepartment of Urology, University of Montreal Hospital Center/Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada. · Pubmed 26262831
  • Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif; Stephane Oudard, Université Paris Descartes, Paris, France; Robert Jones, Institute of Cancer Sciences, University of Glasgow, Glasgow; Johann De Bono, The Institute of Cancer Research, London, United Kingdom; Eleni Efstathiou, University of Athens Medical School, Athens; George Fountzilas, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece; Fred Saad, University of Montreal Hospital Center, Montreal, Canada; Ronald de Wit, Erasmus University Medical Center, Rotterdam, the Netherlands; Felipe Melo Cruz, ABC Foundation School of Medicine, Santo André; Flavio Carcano, Hospital de Cancer de Barretos, Barretos, Brazil; Albertas Ulys, Institut of Oncology, Vilnius University, Vilnius, Lithuania; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; David Agus, University of Southern California, Los Angeles, CA; Daniel P. Petrylak, Yale University Cancer Center, New Haven, CT; Shih-Yuan Lee, Bindu Tejura, Niels Borgstein, Takeda Pharmaceuticals International; Iain J. Webb, Millennium: The Takeda Oncology Company, Cambridge, MA; Robert Dreicer, Cleveland Clinic, Cleveland, OH; Joaquim Bellmunt, University Hospital del Mar-IMIM, Barcelona, Spain. · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif; Stephane Oudard, Université Paris Descartes, Paris, France; Robert Jones, Institute of Cancer Sciences, University of Glasgow, Glasgow; Johann De Bono, The Institute of Cancer Research, London, United Kingdom; Eleni Efstathiou, University of Athens Medical School, Athens; George Fountzilas, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece; Fred Saad, University of Montreal Hospital Center, Montreal, Canada; Ronald de Wit, Erasmus University Medical Center, Rotterdam, the Netherlands; Felipe Melo Cruz, ABC Foundation School of Medicine, Santo André; Flavio Carcano, Hospital de Cancer de Barretos, Barretos, Brazil; Albertas Ulys, Institut of Oncology, Vilnius University, Vilnius, Lithuania; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; David Agus, University of Southern California, Los Angeles, CA; Daniel P. Petrylak, Yale University Cancer Center, New Haven, CT; Shih-Yuan Lee, Bindu Tejura, Niels Borgstein, Takeda Pharmaceuticals International; Iain J. Webb, Millennium: The Takeda Oncology Company, Cambridge, MA; Robert Dreicer, Cleveland Clinic, Cleveland, OH; Joaquim Bellmunt, University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 25624429
2014
  • Ethan Basch, Ronald C. Chen, and Stacie B. Dusetzina, University of North Carolina, Chapel Hill; Derek Raghavan, Carolinas Health Care/Levine Cancer Institute, Charlotte, NC; D. Andrew Loblaw, Odette Cancer Centre, Sunnybrook Health Sciences Centre; Ted Wootton, Patient Representatives, Toronto; Sebastian Hotte and Cindy Walker-Dilks, McMaster University; Cindy Walker-Dilks, Cancer Care Ontario, Hamilton; Eric Winquist, London Health Sciences Centre, London, Ontario; Fred Saad, University of Montreal, Montreal, Quebec, Canada; Thomas K. Oliver and R. Bryan Rumble, American Society of Clinical Oncology, Alexandria, VA; Michael Carducci, Johns Hopkins University, Baltimore, MD; James N. Frame, Charleston Area Medical Center Health Systems, Charleston, WV; Kristina Garrels, Private Practice, Fargo, ND; Michael W. Kattan, Cleveland Clinic, Cleveland, OH; Mary-Ellen Taplin, Dana-Farber Cancer Institute, Boston, MA; James Williams, Pennsylvania Prostate Cancer Coalition, Camp Hill, PA; Charles L. Bennett, South Carolina College of Pharmacy, Columbia, SC; and Katherine S. Virgo, Emory University, Atlanta, GA. · Pubmed 25199761
  • aDepartment of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, USA bCentre Hospitalier de I'Université de Montréal, Hôpital Notre-Dame, Montreal, Canada. · Pubmed 25166424
  • M. Dror Michaelson, Massachusetts General Hospital Cancer Center, Boston, MA; Stephane Oudard, George Pompidou European Hospital, Rene Descartes University, Paris; Nadine Houede, Institut Bergonie, Bordeaux; Tristan Maurina, CHU de Besançon, Hôpital Jean Minjoz, Besançon, France; Yen-Chuan Ou, Taichung Veterans General Hospital, Taichung, Taiwan; Lisa Sengeløv, Herlev Hospital, Herlev; Gedske Daugaard, Rigshospitalet, Copenhagen, Denmark; Fred Saad, University of Montreal, Montreal, Canada; Peter Ostler, Mount Vernon Hospital, Northwood, Middlesex; Robert Jones, Beatson West of Scotland Cancer Centre, Glasgow; Amit Bahl, Bristol Haematology and Oncology Centre, Bristol, UK; Arnulf Stenzl, Eberhard-Karls-University Medical School, Tübingen; Juergen Gschwend, Technical University of Munich, Munich, Germany; Fredrik Laestadius and Anders Ullèn, Karolinska University Hospital, Stockholm, Sweden; Daniel Castellano, I_12 Research Institute, University Hospital 12 de Octubre, Madrid, Spain; Edna Chow Maneval, Shaw-Ling Wang, and Isan Chen, Pfizer Oncology, La Jolla, CA; and Maria Jose Lechuga and Jolanda Paolini, Pfizer Oncology, Milan, Italy. · Pubmed 24323035
2013
  • Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia bThe Division of Urology, University of Montreal Hospital Center (CHUM), University of Montreal, Montreal, Quebec, Canada. · Pubmed 23385973
  • Matthew R. Smith, Massachusetts General Hospital Cancer Center, Boston, MA; Fred Saad, University of Montreal Hospital Center, Montreal, Quebec, Canada; Stephane Oudard, Georges Pompidou Hospital, Paris; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Neal Shore, Carolina Urological Research Center, Myrtle Beach, SC; Paul Sieber, Urological Associates of Lancaster, Lancaster, PA; Bertrand Tombal, Université Catholique de Louvain Cliniques Universitaires Saint Luc, Bruxelles, Belgium; Ronaldo Damiao, Hospital Universitario Pedro Ernesto, Rio de Janeiro, Brazil; Gavin Marx, Sydney Haematology and Oncology Clinic, University of Sydney, Wahroonga, New South Wales, Australia; Kurt Miller, Charité Berlin, Berlin, Germany; Peter Van Veldhuizen, Kansas City Veterans Affairs Medical Center, Kansas City, MO; Juan Morote, Hospital Vall d'Hebron, Barcelona, Spain; and Zhishen Ye, Roger Dansey, and Carsten Goessl, Amgen, Thousand Oaks, CA. · Pubmed 24043751
  • Authors' Affiliations: Departments of Radiation Oncology, Medical Biophysics, Medical Oncology, Laboratory Medicine and Pathology and Biostatistics, University of Toronto; Radiation Medicine Program, Princess Margaret Hospital, University Health Network; Informatics and Bio-Computing Platform, Ontario Institute for Cancer Research, Toronto, Ontario; Department of Cancer Genetics and Developmental Biology, British Columbia Cancer Research Centre; Laboratory for Advanced Genome Analysis - Vancouver Prostate Centre, Vancouver, British Columbia; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, Maryland; Division of Urology, University of Montreal Health Center, Montreal, Quebec; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario; and Department of Pathology and Laboratory Medicine and Oncology, University of Calgary, Calgary, Alberta, Canada. · Pubmed 23918607
  • Département de Biochimie, Université de Montréal, Montréal, Québec H3C 3J7, Canada. · Pubmed 23599344
  • Centre de recherche du Centre hospitalier de l'Université de Montréal, Institut du cancer de Montréal, and Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada. · Pubmed 23541563
2011
  • Departments of Surgery and Urology, Centre Hospitalier de l'Université de Montréal, 1560 Sherbrooke East, Montreal, Quebec H2L 4M1, Canada. · Pubmed 21161451
2010
  • Department of Surgery/Urology, Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montréal, Quebec, Canada. · Pubmed 20224416
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. · Pubmed 20381269
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Pubmed 20117287
2009
  • Department of Urology, University of Montreal Health Center, Montreal, Canada. · Pubmed 19553817
  • Research Centre of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Notre-Dame Hospital and Institut du cancer de Montréal. 1560 Sherbrooke East, Montréal, Québec, Canada. · Pubmed 19552894
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. · Pubmed 19376563
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Canada. · Pubmed 19084864
2008
  • Department of Radiation, University of Montreal Medical Center (CHUM), Montreal, Quebec, Canada. · Pubmed 19046495
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada. · Pubmed 18470914
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. · Pubmed 18384631
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada. · Pubmed 18349404
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Pubmed 17997022
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Pubmed 17996358
2007
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal, Canada. · Pubmed 17996442
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada. · Pubmed 17979925
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montréal, Québec, Canada. · Pubmed 17704404
  • Cancer Prognostics and Health Outcomes Unit, University of Montréal, Montréal, Québec, Canada. · Pubmed 17446004
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 1058, rue St-Denis, Montréal, Que, Canada. · Pubmed 17292604
  • Université de Montréal, Centre de recherche du CHUM et Institut du cancer de Montréal, 1560 Sherbrooke East, Montréal, QC, Canada, H2L 4M1. · Pubmed 17292587
Probable:    Universitat Hamburg      
2012
  • Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany. · Pubmed 22409467
2012
  • Institute of Pathology, Prostate Cancer Center and Section for Translational Prostate Cancer Research at the Clinic of Urology at University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 22705054
2007
  • Department of Urology, University Medical Centre Eppendorf, Hamburg, Germany. · Pubmed 17488305
  • Department of Urology, University Medical Centre, Eppendorf, Hamburg, Germany. · Pubmed 17383807
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 180 total) written by Fred Saad about Prostatic Neoplasms:

  • Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer. 2018
  • Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer. 2018
  • In-hospital length of stay after major surgical oncological procedures. 2018
  • The role of bone-targeted therapies for prostate cancer in 2017. 2017
  • The Role of Therapeutic Layering in Optimizing Treatment for Patients With Castration-resistant Prostate Cancer (Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence II). 2017
  • Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial. 2017
  • Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA. 2017
  • Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer. 2017
  • External Beam Radiotherapy Affects Serum Testosterone in Patients With Localized Prostate Cancer. 2017
  • Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial. 2017
Show List of Full Article Records
Google Searches

Learn more about Fred Saad using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in Montreal
Universite de Montreal
Universitat Hamburg
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in Montreal
2018
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg- Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada; Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy, Vita-Salute San Raffaele University, Milan, Italy. · Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada. · Department of Urology, Istituto Europeo di Oncologia, Milan, Italy. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg- Eppendorf, Hamburg, Germany. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg- Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg- Eppendorf, Hamburg, Germany. · Department of Urology, IRCCS Fondazione Ca' Granda-Ospedale Maggiore Policlinico University of Milan, Milan, Italy. · Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy, Vita-Salute San Raffaele University, Milan, Italy. · Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada. · Pubmed 29784507
2017
  • University of Colorado, Denver, CO. Electronic address: · Yale University, New Haven, CT. · Carolina Urologic Research Center, Myrtle Beach, SC. · Centre Hospitalier de L'Universite de Montreal, Montreal, QC, Canada. · Memorial Sloan Kettering Cancer Center, New York, NY. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV. · Medical University of South Carolina, Charleston, SC. · Banner MD Anderson Cancer Center, Gilbert, AZ. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA. · Queen's University Belfast, Belfast, Northern Ireland, UK. · Université Catholique de Louvain, Brussels, Belgium. · Comprehensive Prostate Center, Nashville, TN. · Lancaster Urology, Lancaster, PA. · Icahn School of Medicine at Mount Sinai, New York, NY. · NRG Immunotherapy and Immunomodulation Committee, Scottsdale, AZ. · University of Washington, Seattle, WA. · Pubmed 28302580
  • OHSU Knight Cancer Institute, Portland, OR, USA. Electronic address: · Juravinski Cancer Centre, Hamilton, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Institut du Cancer de Montréal, Montréal, QC, Canada. · P A Herzen Moscow Cancer Research Institute, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · N N Blokhin Cancer Research Center, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · Centre Leon Berard, Lyon, France. · Institute Paoli-Calmettes, Marseille, France. · Centre François Baclesse, Caen, France. · University of British Columbia, BC Cancer Agency-Vancouver Centre, Vancouver, BC, Canada. · The Clatterbridge Cancer Centre, Bebington, UK. · Trial Architecture Consulting, Washington, DC, USA. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Gustave Roussy, University of Paris Saclay, Villejuif, France. · Pubmed 29033099
  • Department of Medicine, Division of Medical Oncology, University of British Columbia, BC Cancer Agency, Vancouver Prostate Centre, Vancouver, BC, Canada. Electronic address: · Department of Medicine, Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Trial Architecture Consulting, Washington, DC, USA. · Centre Antoine Lacassagne, Nice, France. · Florida Cancer Specialists, Fort Myers, FL, USA. · Department of Urology, Tübingen, Germany. · Institut Paoli Calmette, Department of Cancer Medicine, Marseille, France. · Department of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany. · University of Tübingen, Tübingen, Germany. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON, Canada. · Durham Regional Cancer Centre, Oshawa, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Department of Medicine, Division of Medical Oncology, University of British Columbia, BC Cancer Agency, Vancouver Prostate Centre, Vancouver, BC, Canada. · Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Pubmed 28283282
  • Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Toronto, ON, Canada. · Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900 St Denis St, Montreal, QC, Canada. · McGill University and McGill University Health Centre, 1001 Decarie Blvd, Montreal, QC, Canada. · University Health Network, 610 University Ave, Toronto, ON, Canada. · Manitoba Prostate Centre, 675 McDermot Ave, Winnipeg, MB, Canada. · Department of Surgery Université de Montréal, 2900 Edouard Montpetit Blvd, Montreal, QC, Canada. · Terrry Fox Research Institute, 675 West 10th Avenue, Vancouver, BC, Canada. · Vancouver Prostate Centre, 2660 Oak St, Vancouver, BC, Canada. · Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900 St Denis St, Montreal, QC, Canada. · Department of Surgery Université de Montréal, 2900 Edouard Montpetit Blvd, Montreal, QC, Canada. · Department of Medicine, Université de Montréal, 2900 Edouard Montpetit Blvd, Montreal, QC, Canada. · Pubmed 29078772
  • Duke Cancer Institute, Durham, North Carolina. · Centre Hospitalier de l'Université de Montréal and CRCHUM, Montreal, Quebec, Canada. · Astellas Pharma, Inc., Leiden, Netherlands. · Astellas Pharma, Inc., Northbrook, Illinois. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · Institut Gustave Roussy, University of Paris Sud, Paris, France. · Medivation, Inc., San Francisco, California. · Sidney Kimmel Center for Prostate and Urologic Cancers and Memorial Sloan-Kettering Cancer Center, New York, New York. · Institute of Cancer Research, London, UK. · Pubmed 28171710
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)/Institut du Cancer de Montréal, Montreal, Canada. · Department of Surgery, Hôpital Saint Luc (CHUM), Montreal, Canada. · Department of Surgery, Université de Montréal, Montreal, Canada. · Department of Medicine, Université de Montréal, Montreal, Canada. · Pubmed 27577074
  • University Health Network, Toronto, ON, Canada. · Institut du Cancer de Montréal/Centre de recherche du CHUM, Montreal, QC, Canada. · Manitoba Prostate Center, Winnipeg, MB, Canada. · Centre de Santé et des Services Sociaux de Laval, Laval, QC, Canada. · Centre hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada. · Vancouver Prostate Center, Vancouver, BC, Canada. · Centre de Santé et des Services Sociaux de Chicoutimi, Chicoutimi, QC, Canada. · Centre hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada. · Institut du Cancer de Montréal/Centre de recherche du CHUM, Montreal, QC, Canada. · Pubmed 27447989
2016
  • University of Warwick, Cancer Research Unit, Coventry, UK; Queen Elizabeth Hospital, Birmingham, UK. · Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada. Electronic address: · Pubmed 26905032
  • Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. Electronic address: · Vall d' Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Kantonsspital St Gallen, St Gallen, Switzerland. · University Hospital, University Hospital Cologne, Germany. · Department of Oncology, Akershus University Hospital, Lørenskog, Norway. · Modular Informatics LLC, Thornwood NY, USA. · Biometrical Practice, BIOP, Basel, Switzerland. · Charité University Medicine Berlin, Berlin, Germany. · Karolinska University Hospital, Stockholm, Sweden. · Pharmaceuticals Division of Bayer, Whippany, NJ, USA. · Department of Oncology, San Luigi Hospital, Orbassano Turin, Italy. · University Hospital Carl-Gustav Carus, Dresden, Germany. · Bayer Pharma AG, Basel, Switzerland. · The Centre for Cancer Research and Cell Biology, Queen's University Belfast, Northern Ireland; Northern Ireland Cancer Centre, Belfast, Northern Ireland. · Pubmed 27473888
  • 1 McGill University Health Centre and Research Institute , Montréal, Canada . · 2 PROCURE Alliance , Montréal, Canada . · 3 Montréal University Health Centre , Montréal, Canada . · 4 Québec University Health Centre , Québec, Canada . · 5 Sherbrooke University Health Centre , Sherbrooke, Canada . · Pubmed 27327090
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montréal, Quebec, Canada. Faculté de Pharmacie, Université de Montréal, Pavillon Jean-Coutu, Montréal, Quebec, Canada. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montréal, Quebec, Canada. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montréal, Quebec, Canada. Faculté de Pharmacie, Université de Montréal, Pavillon Jean-Coutu, Montréal, Quebec, Canada. · Pubmed 26253870
2015
  • Montréal University Health Centre, Montréal, Canada. Electronic address: · Department of Cancer Medicine, Gustave Roussy Institute, University of Paris Sud, Villejuif, France. · Pubmed 26282624
  • Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: · Academic Unit of Clinical Oncology, Weston Park Hospital, CR-UK/YCR Sheffield Cancer Research Centre, Sheffield, UK. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA; Department of Clinical Therapeutics, University of Athens, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Department of Internal Medicine, Section of Medical Oncology, UAB Medical Center, Birmingham, AL, USA. · Department of Medicine and Urology, Tulane University, New Orleans, LA, USA. · Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 26153564
  • Division of Urology, Department of Surgery, Centre Hospitalier de I'Université de Montréal, Montréal, Quebec, Canada. Electronic address: · Department of Urology, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany. · Pubmed 25709051
  • Centre Hospitalier de l'Université de Montréal/CRCHUM, Montréal, QC, Canada. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Universitatea de Medicina si Farmacie, Bucharest, Romania. · University of Athens Medical School, Athens, Greece. · Auckland City Hospital, Auckland, New Zealand. · Florida Cancer Specialists, Fort Myers, FL, USA. · Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. · The Adelaide and Meath Hospital, Incorporating the National Children's Hospital, Dublin, Ireland. · University Hospital Carl Gustav Carus Dresden, Dresden, Germany. · Gunma University Graduate School of Medicine, Gunma, Japan. · Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA. · The University of Tokyo Research Center for Advanced Science and Technology, Tokyo, Japan. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Cleveland Clinic, Cleveland, OH, USA. · Millennium Pharmaceuticals, Inc, Cambridge, MA, USA. · Erasmus University Medical Center, Rotterdam, Netherlands. · Pubmed 25701170
  • Epidemiology and Biostatistics Unit, Institut national de la recherche scientifique-Institut Armand-Frappier, University of Quebec, 531 Boul. des Prairies, Laval, QC, H7V 1B7, Canada. · Epidemiology and Biostatistics Unit, Institut national de la recherche scientifique-Institut Armand-Frappier, University of Quebec, 531 Boul. des Prairies, Laval, QC, H7V 1B7, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 1058, rue St-Denis, Montreal, QC, H2X 3 J4, Canada. · Department of Surgery, Division of Urology, Centre Hospitalier de l'Université de Montréal, 1058, rue St-Denis, Montreal, QC, H2X 3 J4, Canada. · Department of Surgery (Urology), McGill University Health Centre, 1650 Cedar Avenue, Montreal, QC, H3G 1A4, Canada. · Department of Surgery, Division of Urology, Centre Hospitalier de l'Université de Montréal, 1058, rue St-Denis, Montreal, QC, H2X 3 J4, Canada. · Epidemiology and Biostatistics Unit, Institut national de la recherche scientifique-Institut Armand-Frappier, University of Quebec, 531 Boul. des Prairies, Laval, QC, H7V 1B7, Canada. · Department of Social and Preventive Medicine, University of Montreal, 7101 Avenue du Parc, Montreal, QC, Canada. · Pubmed 26385727
  • Metamark Genetics Inc., Cambridge, Massachusetts. · Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. · Department of Pathology, Yale University Medical School, New Haven, Connecticut. · Urology Austin, Austin, Texas. · Impacts Inc., Montreal, Quebec, Canada. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio. · Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio. · Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Department of Pathology, Urology and Oncology, Johns Hopkins Hospital, Baltimore, Maryland. · Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 25733599
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Canada; Department of Urology, Vita Salute San Raffaele University, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Canada. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Department of Surgery, Division of Urology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Martini-Klinik, Prostate Cancer Center, University-Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Surgery, Division of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, Canada. · Department of Urology, Vita Salute San Raffaele University, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Canada; Department of Surgery, Division of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, Canada. · Pubmed 25547676
  • Department of Urology, Ruhr University Bochum, Marien Hospital, Herne, Germany. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Québec, Canada. · Department of Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Urology, University of California (UCLA), Los Angeles, CA. · Division of Urologic Surgery and Center for Surgery and Public Health, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Urology, Yale School of Medicine, New Haven, CT. · Department of Urology, Georgetown University Hospital, Washington, DC. · Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · CRCHUM, Centre Hospitalier de l׳Université de Montréal, Montreal, Québec, Canada. · Department of Urology, University of Minnesota, Minneapolis, MN. · Department of Urology, Ruhr University Bochum, Marien Hospital, Herne, Germany. · Division of Urologic Surgery and Center for Surgery and Public Health, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI. · Pubmed 25443265
2014
  • Claude-Bernard-Lyon-1 University and Department of Medical Oncology, Centre Léon-Bérard, Lyon, France. Electronic address: · Multidisciplinary Oncology Institute, Clinique de Genolier, Genolier, Switzerland. · H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. · Claude-Bernard-Lyon-1 University and Department of Medical Oncology, Centre Léon-Bérard, Lyon, France. · Department of Urology, University Hospitals, Leuven, Belgium. · Department of Urology, Queen Mary University of London, London, UK. · Division of Surgery and Interventional Science, University College London, London, UK. · Department of Clinical Therapeutics, University of Athens Medical School, Athens, Greece. · Irish Cancer Society and University College Dublin, Dublin, Ireland. · Department of Urology, RWTH University Aachen, Aachen, Germany. · Guy's and St Thomas' NHS Trust, London, UK. · Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA. · University Hospital, Saint-Etienne, France. · Georges Pompidou Hospital, Department of Oncology, Paris, France. · University College London Hospitals, London, UK. · Uro‑Oncology Clinic, Centre Hospitalier de l'Université de Montreal, Montreal, QC, Canada. · Pubmed 25079103
  • Department of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: · Academic Unit of Clinical Oncology, Weston Park Hospital, CR-UK/YCR Sheffield Cancer Research Centre, Sheffield, UK. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Urology, University Hospital Charité, Berlin, Germany. · Division of Urology, Centre Hospitalier de l'Université de Montréal, CRCHUM, Montréal, QC, Canada. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Tisch Cancer Center Institute, Mount Sinai School of Medicine, New York, NY, USA. · Pubmed 23706567
  • Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. Electronic address: · Pubmed 22633317
2017
  • Division of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 28644302
2015
  • a 1 Institut du cancer de Montréal, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Quebec, Canada. · Pubmed 26313417
  • Department of Radiation Oncology, Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada. · Pubmed 26271398
2013
  • Centre de Recherche, Centre Hospitalier de l'Université de Montréal, 1560 Sherbrooke East, Montréal, QC H2L 4M1, Canada. · Pubmed 23797341
2012
  • Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada. · Pubmed 22871982
  • Goodman Cancer Research Centre, Montréal, Québec, Canada. · Pubmed 22282656
  • Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada. · Pubmed 21932427
2011
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du Cancer de Montréal, Montreal, Quebec, Canada. · Pubmed 21438025
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM)/Institut du Cancer de Montréal, Québec, Canada. · Pubmed 21271611
2010
  • Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM) and Institut du cancer de Montréal, Montreal, Quebec, Canada. · Pubmed 20711410
2009
  • Centre de recherche du Centre hospitalier de l'Université de Montréal/Institut du cancer de Montréal, Québec, Canada. · Pubmed 19170126
2008
  • Centre de recherche du centre hospitalier de l'Université de Montréal (CR-CHUM), Institut du cancer de Montréal, Quebec, Canada. · Pubmed 18294307
2007
  • Urologic-Oncology Division, Centre Hospitalier de l'Université de Montréal, Canada. · Pubmed 18685362
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal and Institut du Cancer de Montréal, Québec, Canada. · Pubmed 18056181
  • Centre de recherche du Centre Hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada. · Pubmed 17532856
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal/Institut du cancer de Montréal, Montréal, Québec, Canada H2L 4M1. · Pubmed 17259348
Universite de Montreal
2017
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Martini Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology, SS Annunziata Hospital, G.D. Annunzio University of Chieti, Chieti, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Martini Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Academic Hospital Braunschweig, Braunschweig, Germany. · Department of Radiation Oncology, University of Montreal Health Center, Montreal, Canada. · Martini Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Martini Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 28546065
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Cancer Medicine, Institute Gustave Roussy, Villejuif, France. · Department of Oncology, University of Paris, Paris, France. · Janssen Oncology Research & Development, Raritan, New Jersey. · Janssen Research & Development, Menlo Park, California. · Millennium Pharmaceuticals Inc., Cambridge, Massachusetts. · Department of Surgery, University of Montréal, Montréal, Québec, Canada. · Prostate Cancer Targeted Therapy Group, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Pubmed 27678453
  • Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. Electronic address: · Duke Cancer Institute, Durham, NC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave-Roussy, Villejuif, France. · San Camillo and Forlanini Hospitals, Rome, Italy. · University of Washington, Seattle Cancer Care Alliance, Seattle, WA, USA. · Rigshospitalet, Copenhagen, Denmark. · UC Davis Cancer Center, Sacramento, CA, USA. · Asan Medical Center, Seoul, Korea. · Nippon Medical School, Tokyo, Japan. · Charité Universitätsmedizin, Berlin, Germany. · University of Montreal Hospital Center, Montreal, QC, Canada. · Skåne University Hospital, Malmö, Sweden. · Aarhus University Hospital, Aarhus, Denmark. · Radboud University Medical Center, Nijmegen, Netherlands. · Tampere University Hospital and University of Tampere, Tampere, Finland. · Medivation, San Francisco, CA, USA. · Astellas Pharma Europe, Leiden, The Netherlands. · Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27477525
  • Janssen Research & Development, 920 Route 202, Raritan, NJ, 08869, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, a Division of Janssen Pharmaceutica NV, Beerse, Belgium. · Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA. · University of Montréal, Montréal, QC, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, 920 Route 202, Raritan, NJ, 08869, USA. · Pubmed 27324190
  • Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Toronto, ON, Canada. · Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900 St Denis St, Montreal, QC, Canada. · McGill University and McGill University Health Centre, 1001 Decarie Blvd, Montreal, QC, Canada. · University Health Network, 610 University Ave, Toronto, ON, Canada. · Manitoba Prostate Centre, 675 McDermot Ave, Winnipeg, MB, Canada. · Department of Surgery Université de Montréal, 2900 Edouard Montpetit Blvd, Montreal, QC, Canada. · Terrry Fox Research Institute, 675 West 10th Avenue, Vancouver, BC, Canada. · Vancouver Prostate Centre, 2660 Oak St, Vancouver, BC, Canada. · Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900 St Denis St, Montreal, QC, Canada. · Department of Surgery Université de Montréal, 2900 Edouard Montpetit Blvd, Montreal, QC, Canada. · Department of Medicine, Université de Montréal, 2900 Edouard Montpetit Blvd, Montreal, QC, Canada. · Pubmed 29078772
  • Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. Electronic address: · University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Research & Development, Beerse, Belgium. · Janssen Global Services, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Pubmed 28314611
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Martini-Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Department of Urology, University Hcoospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Academic Hospital Braunschweig, Braunschweig, Germany. · Pubmed 28156003
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)/Institut du Cancer de Montréal, Montreal, Canada. · Department of Surgery, Hôpital Saint Luc (CHUM), Montreal, Canada. · Department of Surgery, Université de Montréal, Montreal, Canada. · Department of Medicine, Université de Montréal, Montreal, Canada. · Pubmed 27577074
  • The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Centre Hospitalier University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Global Services, Raritan, NJ, USA. · University of Colorado Cancer Center, Aurora, CO, USA. · Pubmed 27402060
2016
  • Department of Urology, UC Davis Comprehensive Cancer Center, Sacramento, CA, USA. Electronic address: · Medical Oncology Division, University of Washington/Seattle Cancer Care Alliance, Seattle, WA, USA. · Department of Urology, Medical University of South Carolina, Charleston, SC, USA. · Division of Urologic Surgery, Washington University School of Medicine, St. Louis, MO, USA. · Department of Surgery, University of Montreal Health Center, Montreal, Canada. · Copenhagen Prostate Cancer Center, Rigshospitalet, University of Copenhagen, Denmark. · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Urology, Asan Medical Center, Seoul, South Korea. · Department of Urology, Nippon Medical School Hospital, Tokyo, Japan. · Division of Medical Oncology and Urology, Duke Cancer Institute, Durham, NC, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave-Roussy, Villejuif, France. · Drug Development Unit, Institute of Cancer Research, Royal Marsden Hospital, London, UK. · Department of Early Clinical Development, Medivation, Inc., San Francisco, CA, USA. · Department of Medical Affairs, Medivation, Inc., San Francisco, CA, USA. · Department of Biostatistics, Medivation, Inc., San Francisco, CA, USA. · Astellas Pharma, Inc., Northbrook, IL, USA. · Department of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27006332
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Janssen Research & Development, San Diego, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · University of Montréal, Montréal, Québec, Canada. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Monash University and Eastern Health, Victoria, Australia. · ZNA Middelheim Oncology Clinic, Medical Oncology, Antwerp, Belgium. · Churchill Hospital, Oxford, UK. · Janssen Research & Development, Menlo Park, CA, USA. · Janssen Research & Development, Beerse, Belgium. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Georges Pompidou Hospital, University René Descartes, Paris, France. · Pubmed 26508309
  • University of Montreal Hospital Center (CHUM) and Montreal Cancer Institute/CRCHUM, CHUM - Pavillon R 900, rue St-Denis, porte R10-464, Montréal, Québec H2X 0A9, Canada. · Pubmed 27489183
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Québec, Canada; Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Québec, Canada; Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Québec, Canada; Department of Urology, University of Montreal Health Center, Montreal, Québec, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Québec, Canada. · Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, Medical University of Vienna and General Hospital, Vienna, Austria. · Department of Urology, University of Montreal Health Center, Montreal, Québec, Canada. · Pubmed 27478167
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, Medical University of Vienna and General Hospital, Vienna, Austria. · Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Pubmed 26951945
  • Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Unit of Urology, Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. · INRS-Institut Armand-Frappier, Institut national de la recherche scientifique, Université du Québec, Laval, Canada. · Department of Social and Preventive Medicine, University of Montreal, Montreal, Canada. · Pubmed 26108732
2015
  • University of Montreal Hospital Center, Montreal, Quebec, Canada. Electronic address: · Pubmed 25168615
  • Centre Hospitalier de l'Université de Montréal, University of Montreal, CHUM Pavillon R, 900 rue St Denis, Montreal, QC H2X 0A9, Canada. · Pubmed 25600097
  • Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (D.B.M., H.S., H.F.), Cambridge, Massachusetts 02139; and University of Montreal Hospital Center (F.S.), Montreal, Québec, Canada H2X 0A9. · Pubmed 26502357
  • Janssen Research & Development, Raritan, New Jersey. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Janssen Research & Development, Beerse, Belgium. · Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · University of Montreal, Montreal, Quebec, Canada. · Janssen Research & Development, Los Angeles, California. · Janssen Research & Development, Raritan, New Jersey. · Pubmed 25829400
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University of Montréal, Montréal, Québec, Canada. · Radboud University Medical Centre, Nijmegen, Netherlands. · San Camillo and Forlanini Hospitals, Rome, Italy. · Charité Berlin, Berlin, Germany. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · University of Western Sydney School of Medicine and Ingham Institute, Liverpool, Australia. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, United Kingdom. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 25601341
  • University of Montreal Hospital Centre, Montreal, QC, Canada. Electronic address: · Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Gustave Roussy, Cancer Campus Grand Paris, University of Paris Sud, Villejuif, France. · Medivation, Inc., San Francisco, CA, USA. · Astellas Global Medical Affairs, Inc., Northbrook, IL, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 25171902
  • Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · INRS-Institut Armand-Frappier, Institut national de la recherche scientifique, Université du Québec, Laval, Canada. · Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · INRS-Institut Armand-Frappier, Institut national de la recherche scientifique, Université du Québec, Laval, Canada; Department of Social and Preventive Medicine, University of Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology, University of Montreal Health Center, Montreal, Canada. · Pubmed 26278366
  • Institut du cancer de Montréal / Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), 900 rue St-Denis, Montreal, Canada. · Visiopharm, Argen Allé 3, Hoersholm, Denmark. · Institut du cancer de Montréal / Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), 900 rue St-Denis, Montreal, Canada; Department of Medicine, Université de Montréal, Montreal, Canada. · Institut du cancer de Montréal / Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), 900 rue St-Denis, Montreal, Canada; Division of Urology, CHUM and Department of Surgery, Université de Montréal, Montreal, Canada. · Pubmed 26186215
  • Department of Surgery, University of Montreal, Montreal, Quebec, Canada. · Pubmed 26181183
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, Montreal, QC, H2X 1P1, Canada. · Department of Urology, University of Montreal Health Center, Montreal, QC, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, Montreal, QC, H2X 1P1, Canada. · Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Division of Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, QC, Canada. · University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada. · Department of Radiation Oncology, University of Montreal Health Center, Montreal, QC, Canada. · Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 25854524
  • Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, Montreal, QC, H2X 1P1, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, Montreal, QC, H2X 1P1, Canada. · Department of Urology, University of Montreal Health Center, Montreal, QC, Canada. · Division of Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · INRS-Institut Armand-Frappier, Institut national de la recherche scientifique, Université du Québec, Laval, QC, Canada. · Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. · Department of Social and Preventive Medicine, University of Montreal, Montreal, QC, Canada. · Pubmed 25824539
  • VUI Center for Outcomes Research, Analytics and Evaluation, Henry Ford Health System, Detroit, MI. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Urology, Yale University, New Haven, CN. · VUI Center for Outcomes Research, Analytics and Evaluation, Henry Ford Health System, Detroit, MI; Division of Urologic Oncology and Center for Surgery and Public Health, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Urology, University of Minnesota, Minneapolis, MN. · Department of Urology, Maine Medical Center, Portland, ME. · Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA. · Division of Urologic Oncology and Center for Surgery and Public Health, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Division of Urology, University of Montreal Hospital Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Division of Urologic Oncology and Center for Surgery and Public Health, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 25623683
2014
  • University of Montreal, Montreal, Quebec, Canada. · Pubmed 25029395
  • Montefiore Medical Center, 111 East 210th Street, New York, NY 10467, USA. · Centre Hospitalier de I'Université de Montréal, Hôpital Notre-Dame, 1560 Sherbrooke East, Montreal, QC H2L 4M1, Canada. · Pubmed 24821212
  • Princess Margaret Hospital, Toronto, ON, Canada. Electronic address: · Durham VA Medical Center and Duke University Medical Center, Durham, NC, USA. · BC Cancer Agency, Vancouver, BC, Canada. · Seattle Cancer Centre Alliance, Seattle, WA, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. · Royal Marsden NHS Foundation Trust, Sutton, UK. · Tulane Cancer Center, New Orleans, LA, USA. · University of Montreal Hospital Center, Montreal, PQ, Canada. · Pubmed 23957948
  • Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. Electronic address: · Hospital Universitario 12 de Octubre, Madrid, Spain. · Rigshospitalet, Copenhagen, Denmark. · National Institute of Oncology, Budapest, Hungary. · McMaster University, Hamilton, ON, Canada. · ICON Cancer Care, Brisbane, QLD, Australia. · University of Montreal, Montreal, QC, Canada. · Center for Oncology, Hospital Sírio-Libanês, São Paulo, Brazil. · OncoCare Cancer Centre, Singapore. · Centro Oncologico Belenus, Cuernavaca, Mexico. · University of Pisa, Pisa, Italy. · Janssen Research & Development, Horsham, PA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Scientific Affairs, Horsham, PA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Global Services, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Duke Cancer Institute, Durham, NC, USA. · Pubmed 25242048
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • Departments of Surgery and Urology, University of Montreal Health Center, Montréal, Quebec, Canada H2X 0A9. · Pubmed 25130993
  • Associated Medical Professionals of New York, Syracuse, NY. · SUNY Upstate Medical University, Syracuse, NY. · Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada. · Associated Medical Professionals of New York, Syracuse, NY. Electronic address: · Division of Urology, University of Montreal Hospital Center, Montreal, Quebec, Canada. · Pubmed 24976229
  • Centre Hospitalier de I'Université de Montréal, Urology Division, Hôpital Notre-Dame, 1560 Sherbrooke Rast, Montreal, QC H2L 4M1, Canada. · Pubmed 24731994
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Urological Research Institute, Vita-Salute San Raffaele University, San Raffaele Hospital, San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Martini-clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Division of Urologic Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 24612110
  • Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: · Janssen Research & Development, Los Angeles, CA, USA. · Medical University of Vienna, Vienna, Austria. · University of Montreal, Montreal, QC, Canada. · University of Washington, Seattle, WA, USA. · British Columbia Cancer Agency, Vancouver, BC, Canada. · Janssen Research & Development, Raritan, NJ, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 24099659
  • University of Montreal Hospital Center, Montreal, Quebec, Canada. Electronic address: · Department of Urology, Charité Berlin, Berlin, Germany. · Pubmed 23506965
2012
  • Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany. · Pubmed 22409467
  • Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montréal, QC, Canada. · Pubmed 22307372
  • Centre Hospitalier de l'Université de Montréal and CRCHUM, 1560 Sherbrooke East, Montréal, Quebec H2L 4M1, Canada. · Pubmed 21864229
  • Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Pubmed 21163673
  • University of Montreal Health Center, Montreal, Quebec, Canada H2L 4M1. · Pubmed 22112794
2011
  • CRCUM-Université de Montréal, Hamilton, Ontario, Canada. · Pubmed 21788353
2010
  • Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Canada. · Pubmed 21110764
  • Centre Hospitalier de l'Université de Montréal, Quebec, Canada. · Pubmed 20682370
  • Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 20489645
  • University of Montreal, CHU Montreal, 1560 Sherbrooke East, Montreal, Quebec, Canada. · Pubmed 20015594
  • Centre Hospitalier de i'Université de Montréal, Hôpital Notre-Dame, Montréal, Quebec, Canada. · Pubmed 21056263
2009
2008
  • Department of Surgery/Urology, Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, Quebec, Canada. · Pubmed 18955443
  • University of Montreal, Montreal, Quebec, Canada. · Pubmed 18070191
  • Centre Hospitalier de I'Université de Montréal, Hôpital Notre-Dame, 1560 Rue Sherbrooke East, Montréal, Quebec, Canada PQ H2L 4M1. · Pubmed 18061356
  • University of Montreal Hospital Centre, Montreal, PQ, Canada. · Pubmed 18510661
2007
  • Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, 1560 Rue Sherbrooke East, Montréal, QC, Canada. · Pubmed 17264863
  • Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montréal, Quebec, Canada. · Pubmed 17956712
2018
  • From the Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago (M.H.), and Astellas Pharma, Northbrook (D.P., A.K.) - both in Illinois; Institut Gustave Roussy, University of Paris Sud, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.); Herlev Hospital, Herlev, Denmark (P.R.); Carolina Urologic Research Center, Myrtle Beach, SC (N.S.); State University of Campinas (Unicamp), Campinas, Brazil (U.F.); Kiev City Clinical Hospital 3, Kiev, Ukraine (P.I.); Pfizer, San Francisco (E.D., K.M.); and the Department of Medical Oncology, San Camillo Forlanini Hospital, Rome (C.N.S.). · Pubmed 29949494
  • From the Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston (M.R.S.); Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal (F.S.); Guy's, King's and St. Thomas' Hospitals, Great Maze Pond, London (S.C.); Georges Pompidou Hospital, Paris (S.O.); University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany (B.A.H.); Veterans Affairs Portland Health Care System, Portland, and Knight Cancer Institute, Oregon Health and Science University, Portland (J.N.G.); Spanish National Cancer Research Center, Madrid, and Hospitales Universitarios Virgen de la Victoria y Regional, Institute of Biomedical Research in Malaga, Malaga - both in Spain (D.O.); Centre for Personalised Nanomedicine, University of Queensland, Brisbane, Australia (P.N.M.); St. Mary's Hospital of Catholic University, Seoul, South Korea (J.Y.L.); Yokohama City University Medical Center, Yokohama, Japan (H.U.); Janssen Research and Development, Los Angeles (A.L.-G., G.C.T., B.M.E., Y.S., Y.C.P., W.R.R., M.K.Y.); and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco (E.J.S.). · Pubmed 29420164
2017
  • Emmanuel S. Antonarakis and Mario A. Eisenberger, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Scott T. Tagawa, Giuseppe Galletti, Daniel Worroll, Karla Ballman, Ada Gjyrezi, Shinsuke Tasaki, Luigi Portella, Yang Bai, Brian J. Kirby, David M. Nanus, and Paraskevi Giannakakou, Weill Cornell Medicine/Meyer Cancer Center; Che-Kai Tsao, Mount Sinai Medical Center, New York; Timothy B. Lannin, Shalu Suri, Conor N. Gruber, Erica D. Pratt, and Brian J. Kirby, Cornell University, Ithaca, NY; Marie Vanhuyse, Medical Oncology, Montréal General Hospital; Fred Saad, University of Montreal Hospital Center, Montreal; John Stewart, Atef Zaher, and Wei Zhou, Sanofi, Laval, Quebec, Canada; Guru Sonpavde, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; Scott North, University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada; Costantine Albany, Indiana University School of Medicine, Indianapolis, IN; and Ted Szatrowski, Sanofi, Bridgewater, NJ. · Pubmed 28632486
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Pubmed 27486887
2015
  • aFaculty of Medicine, University of Montreal bDepartment of Urology, University of Montreal Hospital Center/Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada. · Pubmed 26262831
  • Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif; Stephane Oudard, Université Paris Descartes, Paris, France; Robert Jones, Institute of Cancer Sciences, University of Glasgow, Glasgow; Johann De Bono, The Institute of Cancer Research, London, United Kingdom; Eleni Efstathiou, University of Athens Medical School, Athens; George Fountzilas, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece; Fred Saad, University of Montreal Hospital Center, Montreal, Canada; Ronald de Wit, Erasmus University Medical Center, Rotterdam, the Netherlands; Felipe Melo Cruz, ABC Foundation School of Medicine, Santo André; Flavio Carcano, Hospital de Cancer de Barretos, Barretos, Brazil; Albertas Ulys, Institut of Oncology, Vilnius University, Vilnius, Lithuania; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; David Agus, University of Southern California, Los Angeles, CA; Daniel P. Petrylak, Yale University Cancer Center, New Haven, CT; Shih-Yuan Lee, Bindu Tejura, Niels Borgstein, Takeda Pharmaceuticals International; Iain J. Webb, Millennium: The Takeda Oncology Company, Cambridge, MA; Robert Dreicer, Cleveland Clinic, Cleveland, OH; Joaquim Bellmunt, University Hospital del Mar-IMIM, Barcelona, Spain. · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif; Stephane Oudard, Université Paris Descartes, Paris, France; Robert Jones, Institute of Cancer Sciences, University of Glasgow, Glasgow; Johann De Bono, The Institute of Cancer Research, London, United Kingdom; Eleni Efstathiou, University of Athens Medical School, Athens; George Fountzilas, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece; Fred Saad, University of Montreal Hospital Center, Montreal, Canada; Ronald de Wit, Erasmus University Medical Center, Rotterdam, the Netherlands; Felipe Melo Cruz, ABC Foundation School of Medicine, Santo André; Flavio Carcano, Hospital de Cancer de Barretos, Barretos, Brazil; Albertas Ulys, Institut of Oncology, Vilnius University, Vilnius, Lithuania; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; David Agus, University of Southern California, Los Angeles, CA; Daniel P. Petrylak, Yale University Cancer Center, New Haven, CT; Shih-Yuan Lee, Bindu Tejura, Niels Borgstein, Takeda Pharmaceuticals International; Iain J. Webb, Millennium: The Takeda Oncology Company, Cambridge, MA; Robert Dreicer, Cleveland Clinic, Cleveland, OH; Joaquim Bellmunt, University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 25624429
2014
  • Ethan Basch, Ronald C. Chen, and Stacie B. Dusetzina, University of North Carolina, Chapel Hill; Derek Raghavan, Carolinas Health Care/Levine Cancer Institute, Charlotte, NC; D. Andrew Loblaw, Odette Cancer Centre, Sunnybrook Health Sciences Centre; Ted Wootton, Patient Representatives, Toronto; Sebastian Hotte and Cindy Walker-Dilks, McMaster University; Cindy Walker-Dilks, Cancer Care Ontario, Hamilton; Eric Winquist, London Health Sciences Centre, London, Ontario; Fred Saad, University of Montreal, Montreal, Quebec, Canada; Thomas K. Oliver and R. Bryan Rumble, American Society of Clinical Oncology, Alexandria, VA; Michael Carducci, Johns Hopkins University, Baltimore, MD; James N. Frame, Charleston Area Medical Center Health Systems, Charleston, WV; Kristina Garrels, Private Practice, Fargo, ND; Michael W. Kattan, Cleveland Clinic, Cleveland, OH; Mary-Ellen Taplin, Dana-Farber Cancer Institute, Boston, MA; James Williams, Pennsylvania Prostate Cancer Coalition, Camp Hill, PA; Charles L. Bennett, South Carolina College of Pharmacy, Columbia, SC; and Katherine S. Virgo, Emory University, Atlanta, GA. · Pubmed 25199761
  • aDepartment of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, USA bCentre Hospitalier de I'Université de Montréal, Hôpital Notre-Dame, Montreal, Canada. · Pubmed 25166424
  • M. Dror Michaelson, Massachusetts General Hospital Cancer Center, Boston, MA; Stephane Oudard, George Pompidou European Hospital, Rene Descartes University, Paris; Nadine Houede, Institut Bergonie, Bordeaux; Tristan Maurina, CHU de Besançon, Hôpital Jean Minjoz, Besançon, France; Yen-Chuan Ou, Taichung Veterans General Hospital, Taichung, Taiwan; Lisa Sengeløv, Herlev Hospital, Herlev; Gedske Daugaard, Rigshospitalet, Copenhagen, Denmark; Fred Saad, University of Montreal, Montreal, Canada; Peter Ostler, Mount Vernon Hospital, Northwood, Middlesex; Robert Jones, Beatson West of Scotland Cancer Centre, Glasgow; Amit Bahl, Bristol Haematology and Oncology Centre, Bristol, UK; Arnulf Stenzl, Eberhard-Karls-University Medical School, Tübingen; Juergen Gschwend, Technical University of Munich, Munich, Germany; Fredrik Laestadius and Anders Ullèn, Karolinska University Hospital, Stockholm, Sweden; Daniel Castellano, I_12 Research Institute, University Hospital 12 de Octubre, Madrid, Spain; Edna Chow Maneval, Shaw-Ling Wang, and Isan Chen, Pfizer Oncology, La Jolla, CA; and Maria Jose Lechuga and Jolanda Paolini, Pfizer Oncology, Milan, Italy. · Pubmed 24323035
2013
  • Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia bThe Division of Urology, University of Montreal Hospital Center (CHUM), University of Montreal, Montreal, Quebec, Canada. · Pubmed 23385973
  • Matthew R. Smith, Massachusetts General Hospital Cancer Center, Boston, MA; Fred Saad, University of Montreal Hospital Center, Montreal, Quebec, Canada; Stephane Oudard, Georges Pompidou Hospital, Paris; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Neal Shore, Carolina Urological Research Center, Myrtle Beach, SC; Paul Sieber, Urological Associates of Lancaster, Lancaster, PA; Bertrand Tombal, Université Catholique de Louvain Cliniques Universitaires Saint Luc, Bruxelles, Belgium; Ronaldo Damiao, Hospital Universitario Pedro Ernesto, Rio de Janeiro, Brazil; Gavin Marx, Sydney Haematology and Oncology Clinic, University of Sydney, Wahroonga, New South Wales, Australia; Kurt Miller, Charité Berlin, Berlin, Germany; Peter Van Veldhuizen, Kansas City Veterans Affairs Medical Center, Kansas City, MO; Juan Morote, Hospital Vall d'Hebron, Barcelona, Spain; and Zhishen Ye, Roger Dansey, and Carsten Goessl, Amgen, Thousand Oaks, CA. · Pubmed 24043751
  • Authors' Affiliations: Departments of Radiation Oncology, Medical Biophysics, Medical Oncology, Laboratory Medicine and Pathology and Biostatistics, University of Toronto; Radiation Medicine Program, Princess Margaret Hospital, University Health Network; Informatics and Bio-Computing Platform, Ontario Institute for Cancer Research, Toronto, Ontario; Department of Cancer Genetics and Developmental Biology, British Columbia Cancer Research Centre; Laboratory for Advanced Genome Analysis - Vancouver Prostate Centre, Vancouver, British Columbia; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, Maryland; Division of Urology, University of Montreal Health Center, Montreal, Quebec; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario; and Department of Pathology and Laboratory Medicine and Oncology, University of Calgary, Calgary, Alberta, Canada. · Pubmed 23918607
  • Département de Biochimie, Université de Montréal, Montréal, Québec H3C 3J7, Canada. · Pubmed 23599344
  • Centre de recherche du Centre hospitalier de l'Université de Montréal, Institut du cancer de Montréal, and Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada. · Pubmed 23541563
2011
  • Departments of Surgery and Urology, Centre Hospitalier de l'Université de Montréal, 1560 Sherbrooke East, Montreal, Quebec H2L 4M1, Canada. · Pubmed 21161451
2010
  • Department of Surgery/Urology, Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montréal, Quebec, Canada. · Pubmed 20224416
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. · Pubmed 20381269
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Pubmed 20117287
2009
  • Department of Urology, University of Montreal Health Center, Montreal, Canada. · Pubmed 19553817
  • Research Centre of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Notre-Dame Hospital and Institut du cancer de Montréal. 1560 Sherbrooke East, Montréal, Québec, Canada. · Pubmed 19552894
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. · Pubmed 19376563
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Canada. · Pubmed 19084864
2008
  • Department of Radiation, University of Montreal Medical Center (CHUM), Montreal, Quebec, Canada. · Pubmed 19046495
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada. · Pubmed 18470914
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. · Pubmed 18384631
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada. · Pubmed 18349404
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Pubmed 17997022
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Pubmed 17996358
2007
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal, Canada. · Pubmed 17996442
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada. · Pubmed 17979925
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montréal, Québec, Canada. · Pubmed 17704404
  • Cancer Prognostics and Health Outcomes Unit, University of Montréal, Montréal, Québec, Canada. · Pubmed 17446004
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 1058, rue St-Denis, Montréal, Que, Canada. · Pubmed 17292604
  • Université de Montréal, Centre de recherche du CHUM et Institut du cancer de Montréal, 1560 Sherbrooke East, Montréal, QC, Canada, H2L 4M1. · Pubmed 17292587
Universitat Hamburg
2012
  • Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany. · Pubmed 22409467
2012
  • Institute of Pathology, Prostate Cancer Center and Section for Translational Prostate Cancer Research at the Clinic of Urology at University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 22705054
2007
  • Department of Urology, University Medical Centre Eppendorf, Hamburg, Germany. · Pubmed 17488305
  • Department of Urology, University Medical Centre, Eppendorf, Hamburg, Germany. · Pubmed 17383807
Lund University
2009
113 Other Locations Show
Yearly article counts 3191126211320815111518